Resources

Product

OCALIVA® (obeticholic acid) product information is for informational purposes only and not intended as promotion


Guidelines and Presentations

Select a resource below to view more information on clinical practice guidelines, our congress presentations, research and grant opportunities.

PBC: 2018 AASLD PRACTICE GUIDANCE

VIEW GUIDANCE >

PBC: 2021 AASLD PRACTICE GUIDANCE UPDATE

VIEW GUIDANCE >

PBC: 2019 ACG/CLDF EXPERT OPINION

VIEW >

PBC: 2023 CLDF EXPERT OPINION UPDATE

VIEW >

INTERCEPT CONGRESS PRESENTATIONS

DOWNLOAD PDF >

Educational Practice Tools

The PBC Patient Care Pathway is a tool that allows healthcare professionals to navigate the considerations around diagnosis, treatment, and routine monitoring of patients with PBC and allows the user to select the options that best align with their clinical practice.


Request an MSL Visit

Medical Science Liaisons (MSLs) are your conduit to clinical research, important product information, and disease state education. If you would like a virtual or in-person visit with an Intercept MSL, send an email request to medinfo@interceptpharma.com. Please include your full name, city, and state where you practice (so that we can inform the MSL in your area), the best way to reach you (email and phone number), and the topic of discussion.


Investigator Initiated Research

We support independent, unsolicited research related to progressive non-viral liver diseases. For questions, or to submit a proposal for consideration, email IIR@interceptpharma.com.


Medical Educational Grants

Educational grants may be awarded to academic centers, hospitals, medical societies, professional associations or governmental agencies that sponsor and develop educational programs designed to meet the needs of healthcare professionals, researchers/scientists and patients.


Clinical Trials

We are a company rooted in the pursuit of effective treatments for patients with non-viral liver diseases. Learn more about our current clinical trials.